World Lung Cancer Day With Beth Sandy, MSN, CRNP, and Corey Langer, MD
Keira Smith
Expert Analysis
On August 1st, Oncology Data Advisor hosted a live panel discussion in honor of World Lung Cancer Day, featuring Beth Sandy, MSN, CRNP, and Corey Langer, MD, both of the University of Pennsylvania Abramson Cancer Center. Ms. Sandy and Dr. Langer discussed the improvements in survival that have occurred in recent years due to the development of novel therapies, groundbreaking developments in the fields of immunotherapy and targeted therapy, and exciting advances that lay on the horizon for patients with lung cancer in the coming years.  
Additional Advances in Chemotherapy-Induced Neutropenia Research and Clinical Trials
Lyn Brook
Expert Analysis
Chemotherapy-induced neutropenia (CIN) is a common and potentially life-threatening consequence of chemotherapy, as it may lead to serious infections for patients with cancer. These infections result in hospital stays, increased morbidity and mortality, and considerable financial burden. In this interview, Dr. Maura Abbott explains the importance of managing and educating patients about CIN.  
Epic Experiences Available for Cancer Survivors With Colin Ferro
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Thriving Beyond the Cancer Diagnosis: Colin Ferro At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Colin Ferro, Director of Operations at Epic Experience, spoke with Oncology Data Advisor about the organization's mission to empower adult cancer survivors and thrivers beyond their diagnosis and treatment. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Treatment Advances in Waldenstrom Macroglobulinemia With Morie Gertz, MD, MACP
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Treatment Advances in Waldenstrom Macroglobulinemia Waldenstrom macroglobulinemia (WM) is a rare cancer of B lymphocytes associated with lymphoplasmacytic bone marrow infiltration and the presence of serum monoclonal immunoglobulin M (IgM) (LLS, 2021). Often considered a disease oc...
Understanding Antibody-Drug Conjugates and Their Use in the Treatment of Breast Cancer With Ian Krop, MD, PhD
Elizabeth Heller, PhD
Expert Analysis
Oncology Data Advisor™ · Patritumab Deruxtecan for HER3-Expressing Metastatic Breast Cancer: Ian Krop, MD, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Ian Krop, Director of the Yale Cancer Center Clinical Trials Office, sat down with Oncology Data Advisor to discuss his research and the data he presented regarding the HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) for treatment of metastatic breast cancer.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMED.  
Changing the Standard of Care for Pediatric Neuroblastoma With Wendy London, PhD
Elizabeth Heller, PhD
Expert Analysis
Oncology Data Advisor™ · Neuroblastoma Risk Stratification and Research: Wendy London, PhD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Wendy London, Associate Professor of Pediatrics at Harvard Medical School, sat down with Oncology Data Advisor to share her research regarding risk stratification, reduction of therapy, and survival outcomes for pediatric patients with neuroblastoma. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.
Guiding Colorectal Cancer Treatment Decisions by Using ctDNA With Jeanne Tie, MD, MBChB, FRACP
Elizabeth Heller, PhD
Expert Analysis
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jeanne Tie spoke with Oncology Data Advisor to share more about her presentation regarding the clinical utility of circulating tumor DNA (ctDNA) analysis to guide treatment decision making for patients with colorectal cancer.  
Bridging Disparities in Breast Cancer Morbidity and Mortality in Women of Color With Jessica Jones, MD
Eden Maack
Expert Analysis
Oncology Data Advisor™ · Breast Cancer Prevention and Disparities: Jessica Jones, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Jessica Jones, Assistant Professor of Oncology at the University of Texas (UT) Health System, sat down with Oncology Data Advisor to discuss her work in cancer detection and cancer prevention in Black women with a higher risk of developing breast cancer and bridging the racial gap in breast cancer morbidity and mortality with early detection and prevention.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.
Updates in Mantle Cell Lymphoma With John Leonard, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Updates in Mantle Cell Lymphoma Mantle cell lymphoma (MCL) is an aggressive variant of B-cell non-Hodgkin lymphoma that comprises approximately 5% of all lymphomas. Compared with patients who have other aggressive lymphomas, patients with MCL often do not respond as well to treatment (ACS, 2...
Advancing Treatment for Non–Small Cell Lung Cancer: Exploring the Results of Adagrasib With Alexander Spira, MD, PhD, FACP
Lyn Brook
Expert Analysis
At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Alexander Spira, MD, PhD, FACP, Director of the Thoracic and Phase I Program at the Virginia Cancer Specialists, the US Oncology Network, met with Oncology Data Advisor to discuss his presentation about adagrasib for KRAS G12–mutated non–small cell lung cancer with active central nervous system (CNS) metastases.  
Exploring Treatment Outcomes for Lobular Breast Cancer With Jason Mouabbi, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Lobular Breast Cancer Histology and Research: Jason Mouabbi, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Jason Mouabbi of MD Anderson Cancer Center presented a poster focused on survival outcomes of patients with invasive lobular carcinoma treated with endocrine therapy plus a CDK4/6 inhibitor, mammalian target of rapamycin (mTOR) inhibitor, or a PI3K inhibitor, in comparison to those with metastatic hormone receptor–positive, human epidermal growth factor receptor 2 (HER2)–negative invasive ductal carcinoma. Afterwards, he sat down with Oncology Data Advisor to explain the implication of the study's results and the need for additional research in the field of lobular breast cancer to improve patient outcomes.  This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed.  
Increasing Medical Student Confidence When Treating LGBTQIA+ Patients With Cherry Au, MD
Lyn Brook
Expert Analysis
Following the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Cherry Au, MD, of Rush University Medical Center, spoke with Oncology Data Advisor to discuss her abstract, Medical Student Clinical Cultural Awareness in Cancer Care of Sexual and Gender Minorities.  
Sharing the Breast Cancer Journey From Diagnosis to Survivorship With Megan-Claire Chase
Keira Smith
Expert Analysis
Oncology Data Advisor™ · A Patient's Perspective on Breast Cancer and Advocacy: Megan - Claire Chase At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Megan-Claire Chase, breast cancer survivor and Breast Cancer Program Director at SHARE Cancer Support, sat down with Oncology Data Advisor to talk about her diagnosis, treatment, and survivorship journey, as well as her advocacy work to empower people living with cancer. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Updates in Myelodysplastic Syndromes: Improving Patient Outcomes With Mikkael Sekeres, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Updates in Myelodysplastic Syndromes: Improving Patient Outcomes Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid malignancies that derive from abnormal multipotent progenitor cells and are characterized by bone marrow failure and peripheral blood cytopenias (NCCN, 2021; Garci...
Understanding the Research on Novel Treatments and Nutritional Interventions for Multiple Myeloma With Urvi Shah, MD
Chris West
Expert Analysis
Oncology Data Advisor™ · The Best of Multiple Myeloma Research at ASCO: Urvi Shah, MD During the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dr. Urvi Shah from Memorial Sloan Kettering Cancer Center sat down with Oncology Data Advisor to share her perspectives on the exciting research that was presented in the poster discussion session she chaired on novel therapies for multiple myeloma. In addition, Dr. Shah explains more about her work to impact patients' quality of life and outcomes through nutritional interventions. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Discovering the Field of Ocular Oncology with Dan Gombos, MD, FACS
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Ocular Oncology and the Personalized Approach: Dan Gombos, MD At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Dan Gombos, MD, FACS, of MD Anderson Cancer Center, sat down with Oncology Data Advisor to discuss the field of ocular oncology, the management of tumors that start in or spread to the eye, and the management of toxicity to the eye caused by the treatment of cancer. This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Managing Cancer Care at Home With Kathi Mooney, PhD, RN, FAAN
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Remote Symptom Monitoring and Management: Kathi Mooney, PhD, RN At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Kathi Mooney, PhD, RN, FAAN, Professor in the College of Nursing at the University of Utah, sat down with Oncology Data Advisor to discuss her presentation and abstract about remote symptom management and the Huntsman at Home Rural Experience.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Creating an Inclusive Environment in Your Oncology Practice With Mark Fleming, MD
Lyn Brook
Expert Analysis
At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, Dr. Mark T. Fleming and colleagues, from the Virginia Oncology Associates, presented their poster about their initiative to foster a culture of inclusion in an independent community oncology and hematology practice that specializes in the diagnosis and treatment of cancer and blood disorders.  
Revolutionizing Tissue-Based Research Through Pathology and Artificial Intelligence With Jon Wetzel and Leif Honda
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Biospecimens and AI in Oncology Research: Leif Honda And Jon Wetzel At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jon Wetzel, Chief Operating Officer (COO), and Leif Honda, Chief Innovation Officer (CIO) of TriMetis, a life sciences technology company, sat down with Oncology Data Advisor to talk about using artificial intelligence (AI) and computer-assisted pathology to revolutionize tissue-based research.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 
Perspectives on the Exciting Research at ASCO From Navdeep Dehar, MD, MBT, CCRP
Chris West
Expert Analysis
Oncology Data Advisor™ · Perspectives on the Most Exciting Research at ASCO: Navdeep Dehar, MD At the American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Navdeep Dehar, a Medical Oncology Fellow at Queen's University in Ontario, sat down with Oncology Data Advisor to share the excitement of her first ASCO experience and the valuable research being presented there.This podcast episode was recorded live at the 2022 ASCO Annual Meeting in Chicago by Oncology Data Advisor and ConveyMed. 

Copyright © 2022 Oncology Data Advisor. All rights reserved.